By

t_kogler

Norwegian Start-up KinSea Announces First Closing of Seed Financing

25. April 2024

CasInvent Pharma Raises € 1.6 million in Pre-Series A Financing to Support the Development of CK1 Inhibitors for Treatment-Resistant Solid and Hematological Tumours

30. January 2024

Nodus Oncology raises £1.8m ($2.3m) to extend its seed funding

11. January 2024

Lead Discovery Center GmbH licenses next-generation anticancer drug candidate to HLB Life Science R&D

2. November 2023

Norwegian Start-up KinSea to Exploit the Potential of Marine Bioactives for the Treatment of Cancer and other Diseases

8. February 2023

Nodus Oncology Secures £2.4m ($2.9m) Investment

7. February 2023

CalTIC

17. November 2022

Start-up CalTIC secures up to EUR 3 million in seed financing to develop a new class of drugs targeting TRPC channels

27. September 2022

CasInvent Pharma Raises €1.3 Million from KHAN-I and i&i Biotech Fund

13. September 2022

Recent Comments

    Categories